Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis

Brittni A Scruggs; Sajag Bhattarai; Ioana Cherascu; Megan Helms; Adisa Salesevic; Joseph Laird; Sheila A Baker; Budd Tucker; Arlene V Drack

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4212. doi:

ARVO Annual Meeting Abstract July 2019

CEP290 -associated LCA due to a photoreceptor cilium defect treated with an intravitreal antisense oligonucleotide results in improved vision

Artur V Cideciyan; Samuel G Jacobson; Arlene V Drack; Allen C Ho; Alexandra Garafalo; Alejandro J Roman; Mike Schwartz; Patricia Biasutto; Wilma de Wit; Michael E Cheetham; Peter S Adamson; David Rodman; Julie De Zaeytijd; Caroline Van Cauwenbergh; Bart P Leroy; Stephen R Russell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1834. doi:

ARVO Annual Meeting Abstract July 2018

Determination of the optimal time window for gene replacement therapies for blindness using an inducible rescue mouse model of Bardet-Biedl Syndrome

Ying Hsu; Janelle Garrison; Gunhee Kim; Arlene V Drack; Darryl Nishimura; Seongjin Seo; Val C. Sheffield

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3962. doi:

ARVO Annual Meeting Abstract June 2017

Severe congenital stationary night blindness due to GUCY2D mutations

Scott E Brodie; Arlene V Drack; Edwin M Stone

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2773. doi:

ARVO Annual Meeting Abstract June 2017

Whole genome sequencing to find missing alleles in patients with retinal disease.

Adam P DeLuca; Heather T Daggett; Jade S East; Arlene V Drack; Todd E Scheetz; Val Sheffield; Edwin M Stone

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2756. doi:

ARVO Annual Meeting Abstract September 2016

Electrophysiology and anatomy of the retina in albinism: is there a correlation with visual acuity?

Arlene V Drack; Zhaohui hu; Taylor Kehoe; Andrew Kemerley; Megan Helms; Sajag Bhattarai; wanda pfeifer

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3602. doi:

ARVO Annual Meeting Abstract June 2015

Accumulation of non-outer segment proteins in the outer segment underlies photoreceptor degeneration in BBS

Seongjin Seo; Poppy Datta; Chantal Allamargot; Joseph Hudson; Emily Andersen; Sajag Bhattarai; Arlene V Drack

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4644. doi:

ARVO Annual Meeting Abstract June 2015

Effect of operating microscope light on retinal function in common laboratory mice strains

Arlene V Drack; Uma Balakrishnan; Andrew Kemerley; Nicole Tatro; Alina Valentina Dumitrescu; Stewart Thompson; Sajag Bhattarai

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5415. doi:

ARVO Annual Meeting Abstract June 2015

Genetic testing for congenital cataract

Matthew C Weed; Scott R Lambert; Scott A Larson; Richard J Olson; Susannah Q Longmuir; Adam P DeLuca; Elizabeth L Kennedy; Edwin M Stone; Arlene V Drack

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2526. doi:

ARVO Annual Meeting Abstract April 2014

Is TRPM1 associated Congenital Stationary Night Blindness stationary?

Wanda L Pfeifer; Richard J Olson; Susannah Q Longmuir; Arlene V Drack

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3287. doi:

ARVO Annual Meeting Abstract April 2014

CEP290 gene addition rescues ciliogenesis in LCA patient cells.

Erin R Burnight; Luke A Wiley; Arlene V Drack; Terry A Braun; Kristin Anfinson; Emily E Kaalberg; Jennifer Halder; Robert Mullins; Edwin M Stone; Budd A Tucker

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3300. doi:

ARVO Annual Meeting Abstract April 2014

Distinct profiles of abnormal ganglion cell activity in two forms of Leber’s congenital amaurosis (LCA): Implications for therapy

Steven F Stasheff; Kelsey N Spalding; Frederick R Blodi; Malini Shankar; Sajag Bhattarai; Stewart Thompson; Jeannette Bennicelli; Jean Bennett; Arlene V Drack

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):357. doi:

ARVO Annual Meeting Abstract April 2014

Using stem cells to develop gene therapy for Batten Disease.

Budd A Tucker; Luke A Wiley; Kristin Anfinson; Dalyz Ochoa; Jeaneen Andorf; Louisa M Affatigato; Arlene V Drack; Edwin M Stone

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3986. doi:

ARVO Annual Meeting Abstract April 2014

Overcoming the overexpression toxicity of gene replacement therapy for Bardet Biedl Syndrome type 1

Arlene V Drack; Sajag Bhattarai; Seongjin Seo; Edwin M Stone; Val Sheffield; Robert Mullins; Budd A Tucker

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4378. doi:

ARVO Annual Meeting Abstract April 2014

Using patient-derived iPSCs to identify new drug treatments for JNCL

Luke A Wiley; Kristin Anfinson; Emily E Kaalberg; Suruchi Shrestha; Svetha Swaminathan; Arlene V Drack; Robert Mullins; Edwin M Stone; Budd A Tucker

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2675. doi:

ARVO Annual Meeting Abstract April 2014

Gene Therapy for MAK-associated RP

Edwin M Stone; Arlene V Drack; Rebecca M Johnston; Heather T Daggett; Jeremy M Hoffmann; Christine M Hass; Jessica A Penticoff; Malia M Collins; Robert Mullins; Budd A Tucker

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2676. doi:

Translational Research September 2013

Subretinal Gene Therapy of Mice With Bardet-Biedl Syndrome Type 1

PDF

Seongjin Seo; Robert F. Mullins; Alina V. Dumitrescu; Sajag Bhattarai; Daniel Gratie; Kai Wang; Edwin M. Stone; Val Sheffield; Arlene V. Drack
TAGS: gene therapy, bardet-biedl syndrome, electroretinography, eye, mice, proteins, retina, toxic effect, spatial vectors
Invest. Ophthalmol. Vis. Sci.. 2013; 54(9):6118-6132. doi: 10.1167/iovs.13-11673

Includes: Supplemental Content

ARVO Annual Meeting Abstract March 2012

Subretinal gene therapy in Bbs1 mice

Arlene V. Drack; Sajag Bhattarai; Seongjin Seo; Dan Gratie; Edwin M. Stone; Robert Mullins; Val Sheffield

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6566. doi:

Translational Research January 2012

TUDCA Slows Retinal Degeneration in Two Different Mouse Models of Retinitis Pigmentosa and Prevents Obesity in Bardet-Biedl Syndrome Type 1 Mice

PDF

Arlene V. Drack; Alina V. Dumitrescu; Sajag Bhattarai; Daniel Gratie; Edwin M. Stone; Robert Mullins; Val C. Sheffield
TAGS: obesity, bardet-biedl syndrome, electroretinography, retinal degeneration, retinitis pigmentosa, histology, mice
Invest. Ophthalmol. Vis. Sci.. 2012; 53(1):100-106. doi: 10.1167/iovs.11-8544

ARVO Annual Meeting Abstract April 2011

Etiology of Isolated Infantile Nystagmus in a Tertiary Care Pediatric Ophthalmology Practice

Michael S. Floyd; Susannah Q. Longmuir; Richard J. Olson; Tiffany Grider; Arlene V. Drack

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4706. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis

CEP290 -associated LCA due to a photoreceptor cilium defect treated with an intravitreal antisense oligonucleotide results in improved vision

Determination of the optimal time window for gene replacement therapies for blindness using an inducible rescue mouse model of Bardet-Biedl Syndrome

Severe congenital stationary night blindness due to GUCY2D mutations

Whole genome sequencing to find missing alleles in patients with retinal disease.

Electrophysiology and anatomy of the retina in albinism: is there a correlation with visual acuity?

Accumulation of non-outer segment proteins in the outer segment underlies photoreceptor degeneration in BBS

Effect of operating microscope light on retinal function in common laboratory mice strains

Genetic testing for congenital cataract

Is TRPM1 associated Congenital Stationary Night Blindness stationary?

CEP290 gene addition rescues ciliogenesis in LCA patient cells.

Distinct profiles of abnormal ganglion cell activity in two forms of Leber’s congenital amaurosis (LCA): Implications for therapy

Using stem cells to develop gene therapy for Batten Disease.

Overcoming the overexpression toxicity of gene replacement therapy for Bardet Biedl Syndrome type 1

Using patient-derived iPSCs to identify new drug treatments for JNCL

Gene Therapy for MAK-associated RP

Subretinal Gene Therapy of Mice With Bardet-Biedl Syndrome Type 1

Subretinal gene therapy in Bbs1 mice

TUDCA Slows Retinal Degeneration in Two Different Mouse Models of Retinitis Pigmentosa and Prevents Obesity in Bardet-Biedl Syndrome Type 1 Mice

Etiology of Isolated Infantile Nystagmus in a Tertiary Care Pediatric Ophthalmology Practice

To View More...

You must be signed into an individual account to use this feature.